Dentin Hypersensitivity - Varnish or Laser?

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSigmund Freud PrivatUniversitat

About this trial

Dentin hypersensitivity is a common condition described as a short and sharp pain caused by thermal, evaporative, tactile, osmotic, or chemical stimuli to exposed dentin that cannot be related to another defect or dental pathology. The variety of treatment options and products on the market might seem overwhelming. This study aims to show that laser treatments are efficient in reducing pain scores compared to a desensitizing agent (Gluma). 80 patients with at least two hypersensitive teeth will be enrolled in this study. Patients will be divided randomly into four groups (control group (Gluma), laser group 1 (2.94 µm wavelength), laser group 2 (1064 nm wavelength), laser group 3 (970 nm wavelength)). Visual Analog Scale will be measured before treatment, right after treatment, one week after treatment, one month after treatment, three months after treatment. Mixed Anova's and descriptive analysis will be used for statistical evaluation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

all genders

18-70 years

good general health

at least two hypersensitive teeth in either jaw

Disqualifiers

Active carious lesions, insufficient restorations, enamel cracks, reversible pulpitis

Active periodontal disease, periodontal surgery (in the last 6 months)

Bleaching procedure in the last 3 months

Analgetic use in the last 72 hours

Trial design

Design model

Parallel

Treatments tested in this trial

  • Laser Irradiation

    Device

    three different laser wavelengths will be used

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: ControlActive comparator 1 intervention
Group B: 1. Laser GroupActive comparator 1 intervention
Group C: 2. Laser GroupActive comparator 1 intervention
Group D: 3. Laser GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analog Scale changes

Patients will rate pain score with VAS. Pain scores will be evaluated before treatment, right after treatment, one week later, one month later and three months later

Time frame
three months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: